[Functional state of thrombocytes in Yersinia infection]. 1991

A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev

As many as 94 patients with yersiniosis were examined for the morphofunctional status of platelets (aggregation, disaggregation, endo-exocytosis and platelet forms). The data indicate that platelet from patients with yersiniosis possess a high ability for aggregation and a low ability for disaggregation. According to the experimental and clinical data, emoxipine can restore disturbed function of human platelets.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D010847 Picolines A group of compounds that are monomethyl derivatives of pyridines. (From Dorland, 28th ed) Picoline
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D015008 Yersinia enterocolitica A species of the genus YERSINIA, isolated from both man and animal. It is a frequent cause of bacterial gastroenteritis in children. Bacterium enterocoliticum
D015009 Yersinia Infections Infections with bacteria of the genus YERSINIA. Yersinia Infection,Infections, Yersinia,Yersinia enterocolitica Infection,Yersiniosis,Infection, Yersinia,Yersinia enterocolitica Infections,Yersinioses

Related Publications

A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev
September 1972, Problemy gematologii i perelivaniia krovi,
A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev
March 1974, Klinicheskaia meditsina,
A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev
October 1970, Kardiologiia,
A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev
January 1972, Kardiologiia,
A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev
November 1993, Biulleten' eksperimental'noi biologii i meditsiny,
A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev
June 1987, Vestnik khirurgii imeni I. I. Grekova,
A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev
June 1975, Voprosy okhrany materinstva i detstva,
A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev
February 1986, Pediatriia,
A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev
October 1983, Kardiologiia,
A V Kravchenko, and Kh D Lomazova, and A M Poliakova, and L I Buriachkovskaia, and E Iu Novoselova, and V V Maleev
October 1961, Terapevticheskii arkhiv,
Copied contents to your clipboard!